BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31769844)

  • 1. Pituitary Adenomas in Transgender Individuals?
    Kleinschmidt-DeMasters BK
    J Neuropathol Exp Neurol; 2020 Jan; 79(1):62-66. PubMed ID: 31769844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment.
    Nota NM; Wiepjes CM; de Blok CJM; Gooren LJG; Peerdeman SM; Kreukels BPC; den Heijer M
    Brain; 2018 Jul; 141(7):2047-2054. PubMed ID: 29688280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent trends in the pathophysiology and treatment of pituitary adenomas].
    Matsuno A
    Brain Nerve; 2009 Aug; 61(8):957-62. PubMed ID: 19697885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotroph adenoma with secondary hypersecretion of testosterone.
    Chamoun R; Layfield L; Couldwell WT
    World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of systemic sclerosis in transgender females: a case series and review of the literature.
    Campochiaro C; Host LV; Ong VH; Denton CP
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):50-52. PubMed ID: 29465362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperprolactinemia and association with prolactinoma in transwomen receiving gender affirming hormone treatment.
    Raven LM; Guttman-Jones M; Muir CA
    Endocrine; 2021 May; 72(2):524-528. PubMed ID: 33398769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotroph cell adenomas of the pituitary.
    Snyder PJ
    Endocr Rev; 1985; 6(4):552-63. PubMed ID: 2416559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transsphenoidal surgery for pituitary adenomas in children.
    Dyer EH; Civit T; Visot A; Delalande O; Derome P
    Neurosurgery; 1994 Feb; 34(2):207-12; discussion 212. PubMed ID: 8177379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of pituitary adenomas].
    Mezosi E; Nemes O
    Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gonadotroph pituitary adenomas].
    Chanson P
    Ann Endocrinol (Paris); 2000 Sep; 61(3):258-68. PubMed ID: 10970952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexisting corticotroph and lactotroph adenomas: case report with reference to the relationship of corticotropin and prolactin excess.
    Wynne AG; Scheithauer BW; Young WF; Kovacs K; Ebersold MJ; Horvath E
    Neurosurgery; 1992 Jun; 30(6):919-23. PubMed ID: 1319562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surgical treatments for 7 pituitary adenomas in multiple endocrine neoplasia type 1].
    Tanaka Y; Hongo K; Tada T; Takizawa T; Kakizawa Y; Koyama J; Kobayashi S; Sakurai A; Hashizume K
    No Shinkei Geka; 2000 Dec; 28(12):1087-92. PubMed ID: 11193530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology of prolactinomas: any predictive value?
    Lopes MBS
    Pituitary; 2020 Feb; 23(1):3-8. PubMed ID: 31641970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of pituitary adenomas.
    Chanson P; Salenave S
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral vectors efficiently transduce human gonadotroph and somatotroph adenomas in vitro. Targeted expression of transgene by pituitary hormone promoters.
    Roche C; Zamora AJ; Taïeb D; Lavaque E; Rasolonjanahary R; Dufour H; Bagnis C; Enjalbert A; Barlier A
    J Endocrinol; 2004 Oct; 183(1):217-33. PubMed ID: 15525589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
    Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
    Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Feminizing Hormones on Sperm Production and Malignant Changes: Microscopic Examination of Post Orchiectomy Specimens in Transwomen.
    Kent MA; Winoker JS; Grotas AB
    Urology; 2018 Nov; 121():93-96. PubMed ID: 30092303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related and gender-related occurrence of pituitary adenomas.
    Mindermann T; Wilson CB
    Clin Endocrinol (Oxf); 1994 Sep; 41(3):359-64. PubMed ID: 7893282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic Findings in Surgical Pathology Specimens From Individuals Taking Feminizing Hormone Therapy for the Purpose of Gender Transition.
    Andrews AR; Kakadekar A; Schmidt RL; Murugan P; Greene DN
    Arch Pathol Lab Med; 2022 Jan; 146(2):252-261. PubMed ID: 33983412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated double pituitary adenomas: A silent corticotroph adenoma and a microprolactinoma.
    Eytan S; Kim KY; Bleich D; Raghuwanshi M; Eloy JA; Liu JK
    J Clin Neurosci; 2015 Oct; 22(10):1676-8. PubMed ID: 26067545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.